131 related articles for article (PubMed ID: 34183450)
1. REX-1 Represses RASSF1a and Activates the MEK/ERK Pathway to Promote Tumorigenesis in Prostate Cancer.
Liu W; Xie A; Tu C; Liu W
Mol Cancer Res; 2021 Oct; 19(10):1666-1675. PubMed ID: 34183450
[TBL] [Abstract][Full Text] [Related]
2. Mahanine restores RASSF1A expression by down-regulating DNMT1 and DNMT3B in prostate cancer cells.
Agarwal S; Amin KS; Jagadeesh S; Baishay G; Rao PG; Barua NC; Bhattacharya S; Banerjee PP
Mol Cancer; 2013 Aug; 12(1):99. PubMed ID: 24001151
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells.
Boyanapalli SS; Li W; Fuentes F; Guo Y; Ramirez CN; Gonzalez XP; Pung D; Kong AN
Pharmacol Res; 2016 Dec; 114():175-184. PubMed ID: 27818231
[TBL] [Abstract][Full Text] [Related]
4. DNMT1 and DNMT3B regulate tumorigenicity of human prostate cancer cells by controlling RAD9 expression through targeted methylation.
Zhu A; Hopkins KM; Friedman RA; Bernstock JD; Broustas CG; Lieberman HB
Carcinogenesis; 2021 Feb; 42(2):220-231. PubMed ID: 32780107
[TBL] [Abstract][Full Text] [Related]
5. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
6. Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer.
Hoffmann MJ; Engers R; Florl AR; Otte AP; Muller M; Schulz WA
Cancer Biol Ther; 2007 Sep; 6(9):1403-12. PubMed ID: 18637271
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic modifications of RASSF1A gene through chromatin remodeling in prostate cancer.
Kawamoto K; Okino ST; Place RF; Urakami S; Hirata H; Kikuno N; Kawakami T; Tanaka Y; Pookot D; Chen Z; Majid S; Enokida H; Nakagawa M; Dahiya R
Clin Cancer Res; 2007 May; 13(9):2541-8. PubMed ID: 17473182
[TBL] [Abstract][Full Text] [Related]
8. HIC1 modulates prostate cancer progression by epigenetic modification.
Zheng J; Wang J; Sun X; Hao M; Ding T; Xiong D; Wang X; Zhu Y; Xiao G; Cheng G; Zhao M; Zhang J; Wang J
Clin Cancer Res; 2013 Mar; 19(6):1400-10. PubMed ID: 23340301
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic silencing of the RASSF1A tumor suppressor gene through HOXB3-mediated induction of DNMT3B expression.
Palakurthy RK; Wajapeyee N; Santra MK; Gazin C; Lin L; Gobeil S; Green MR
Mol Cell; 2009 Oct; 36(2):219-30. PubMed ID: 19854132
[TBL] [Abstract][Full Text] [Related]
10. ATRA inhibits the proliferation of DU145 prostate cancer cells through reducing the methylation level of HOXB13 gene.
Liu Z; Ren G; Shangguan C; Guo L; Dong Z; Li Y; Zhang W; Zhao L; Hou P; Zhang Y; Wang X; Lu J; Huang B
PLoS One; 2012; 7(7):e40943. PubMed ID: 22808286
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of DNMT1 mediated by HBx suppresses RASSF1A expression independent of DNA methylation.
Qiu X; Zhang L; Lu S; Song Y; Lao Y; Hu J; Fan H
Oncol Rep; 2014 Jan; 31(1):202-8. PubMed ID: 24247422
[TBL] [Abstract][Full Text] [Related]
12. DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis.
Lee E; Wang J; Yumoto K; Jung Y; Cackowski FC; Decker AM; Li Y; Franceschi RT; Pienta KJ; Taichman RS
Neoplasia; 2016 Sep; 18(9):553-66. PubMed ID: 27659015
[TBL] [Abstract][Full Text] [Related]
13. Fluorescent epigenetic small molecule induces expression of the tumor suppressor ras-association domain family 1A and inhibits human prostate xenograft.
Sheikh KD; Banerjee PP; Jagadeesh S; Grindrod SC; Zhang L; Paige M; Brown ML
J Med Chem; 2010 Mar; 53(6):2376-82. PubMed ID: 20184324
[TBL] [Abstract][Full Text] [Related]
14. The association between RASSF1A promoter methylation and prostate cancer: evidence from 19 published studies.
Ge YZ; Xu LW; Jia RP; Xu Z; Feng YM; Wu R; Yu P; Zhao Y; Gui ZL; Tan SJ; Song Q
Tumour Biol; 2014 Apr; 35(4):3881-90. PubMed ID: 24353088
[TBL] [Abstract][Full Text] [Related]
15. EBNA3C facilitates RASSF1A downregulation through ubiquitin-mediated degradation and promoter hypermethylation to drive B-cell proliferation.
Zhang S; Pei Y; Lang F; Sun K; Singh RK; Lamplugh ZL; Saha A; Robertson ES
PLoS Pathog; 2019 Jan; 15(1):e1007514. PubMed ID: 30615685
[TBL] [Abstract][Full Text] [Related]
16. PLZF mediates the PTEN/AKT/FOXO3a signaling in suppression of prostate tumorigenesis.
Cao J; Zhu S; Zhou W; Li J; Liu C; Xuan H; Yan J; Zheng L; Zhou L; Yu J; Chen G; Huang Y; Yu Z; Feng L
PLoS One; 2013; 8(12):e77922. PubMed ID: 24339862
[TBL] [Abstract][Full Text] [Related]
17. Impact of RASSF1A gene methylation on clinico-pathological features of tumor and non-tumor tissue of breast cancer.
Gupta V; Agarwal P; Deshpande P
Ann Diagn Pathol; 2021 Jun; 52():151722. PubMed ID: 33621744
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA LINC00673 silencing inhibits proliferation and drug resistance of prostate cancer cells via decreasing KLF4 promoter methylation.
Jiang Z; Zhang Y; Chen X; Wu P; Chen D
J Cell Mol Med; 2020 Jan; 24(2):1878-1892. PubMed ID: 31881124
[TBL] [Abstract][Full Text] [Related]
19. [Methylation of the RASSF1A tumor suppressor gene promoter. Risk factor for carcinogenesis of urological tumors].
Serth J; Tezval H; Peters I; Atschekzei F; Rehmet K; Jurk S; Albrecht K; Kuczyk MA; Merseburger AS
Urologe A; 2008 Sep; 47(9):1117-8, 1120-1. PubMed ID: 18679651
[TBL] [Abstract][Full Text] [Related]
20. MUC1-C represses the RASSF1A tumor suppressor in human carcinoma cells.
Rajabi H; Hata T; Li W; Long MD; Hu Q; Liu S; Raina D; Kui L; Yasumizu Y; Hong D; Samur M; Kufe D
Oncogene; 2019 Nov; 38(47):7266-7277. PubMed ID: 31435022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
